Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistant Partial Onset Seizure”

12 trials

Showing 12 of 12 results

Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Large-scale testing (Phase 3)Ended earlyNCT01648101
What this trial is testing

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline 76
Not applicableStudy completedNCT01281280
What this trial is testing

PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1

Who this might be right for
Epilepsy
Cyberonics, Inc. 81
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Testing effectiveness (Phase 2)Ended earlyNCT02625090
What this trial is testing

An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma SRL 42
Large-scale testing (Phase 3)Ended earlyNCT02519439
What this trial is testing

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 26
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Large-scale testing (Phase 3)Looking for participantsNCT06309966
What this trial is testing

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Large-scale testing (Phase 3)Study completedNCT01777139
What this trial is testing

A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06443463
What this trial is testing

Long-term Safety and Tolerability of BHV-7000

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 660

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation